SARS-CoV-2 Sequencing

Brief Description

Whole genome sequencing for the characterization of SARS-CoV-2 variants. This testing is for surveillance-use only.

Laboratory Unit

Molecular

Methodology

Whole Genome Sequencing (WGS)

Specimen Collection

Collection and Submission of Influenza & SARS-CoV-2 Specimens for Virologic Surveillance

Storage/Transport

Collection and Submission of Influenza & SARS-CoV-2 Specimens for Virologic Surveillance

Acceptable Specimen Type(s)

Respiratory swab in Viral Transport Media (VTM) or Saline

Test Request Form(s)

Virology Test Request Form REQUIRED

Possible Results

Due to federal regulation, the MSPHL is unable to provide result reports for SARS-CoV-2 variant sequencing surveillance to the submitter or patient. SARS-CoV-2 variant surveillance whole genome sequencing is intended for public health surveillance purposes only and cannot be used for diagnostic or individual clinical patient management. This method is not FDA cleared or CLIA regulated.

Unacceptable Conditions

  • The name on the specimen does not match the name on the requisition form.
  • The specimen container is not labeled with the patient’s name.
  • Improper storage/transport of specimen.
  • The sample collected with improper collection device—cotton-tipped or calcium-alginate swab, wooden-shaft swab, transport media not intended for viruses.
  • The specimen is not one of the listed acceptable specimens.
  • Quantity Not Sufficient for testing

Interfering Substances

Cotton-tipped or calcium-alginate swab, wooden-shaft swab, transport media not intended for viruses

Result Reported

N/A

Fees

None

CPT Codes

N/A

LOINC/SNOMED Codes

N/A

Additional Information

Cases, Data, and Surveillance-CDC